Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
In the coming years, several trends are likely to emerge: Rapid growth in the number of oral GLP-1 drugs Small-molecule GLP-1 therapies becoming a major R&D focus Manufacturing capacity becoming a key competitive factor Continued entry of emerging biotechnology companies into the sector At the same time, dual-target GLP-1 drugs , GLP-1/GIP co-agonists , and oral multi-target metabolic therapies are also advancing rapidly
It is available in both pre-filled pens and pre-filled syringes, making it easy for patients to self-administer
Changes in blood sugar or weightcommon effects of tirzepatidecan sometimes affect menstrual cycles, so its important to take note if anything unusual occurs
Plateaus common long-term
2020;9(1):e012940
US$ 26.16
US$ 24.15
US$ 23.13
US$ 22.38
US$ 28.38
US$ 27.93
US$ 20.84
US$ 29.90
